Topische Therapie bei Colitis ulcerosa [Topical therapy of ulcerative colitis].


Autoria(s): Rogler G.; Beglinger C.; Mottet C.; Seibold F.; Gross V.
Data(s)

2011

Resumo

The availability of new topical preparations for the treatment of left sided ulcerative colitis ulcerosa offers a therapy optimization for many patients. Rectal application of steroids and 5-aminosalicylic acid (5-ASA) is associated with fewer side effects and has a higher therapeutic efficacy in mild to moderate-active left-sided colitis as compared to a systemic therapy. Often it is argued that the patients' compliance is insufficient with a rectal therapy. However, with sufficient information on the proven advantages this is usually not the case. The rectal application of drugs in distal ulcerative colitis is suitable also for the maintenance of remission. Therefore the new therapy guidelines recommend topical therapy more than in former times. Subsequently, these manuscripts focussed specifically on the topical therapy of distal colitis, to elucidate that clear treatment advantages are present in daily practice.

Identificador

http://serval.unil.ch/?id=serval:BIB_1EB35BF6704D

isbn:1661-8157 (Print)

pmid:22086380

doi:10.1024/1661-8157/a000722

Idioma(s)

de

Fonte

Praxis, vol. 100, no. 23, pp. 1413-1424

Palavras-Chave #Administration, Rectal; Adrenal Cortex Hormones/administration & dosage; Algorithms; Anti-Inflammatory Agents, Non-Steroidal/administration & dosage; Colitis, Ulcerative/drug therapy; Colonoscopy; Guideline Adherence; Humans; Immunosuppressive Agents/administration & dosage; Mesalamine/administration & dosage
Tipo

info:eu-repo/semantics/review

article